Since then, other GLP-1 analogues have been approved including lixisenatide, liraglutide, dulaglutide, albiglutide, and semaglutide
GLP-1 medications can contribute to dehydration indirectly if nausea, vomiting, diarrhea, constipation, or reduced appetite lowers fluid intake
The MHRA-approved SmPC specifically warns that dehydration from these gastrointestinal effects may precipitate acute kidney injury, which could present with reduced urine output
The importance of coordinated care Autoimmune patients considering tirzepatide should ideally have their prescribing provider coordinate with their rheumatologist, immunologist, or relevant specialist
Plasma, liver, and epididymal fat pad samples were harvested for analysis
Sastry KS, Naeem H, Mokrab Y, Chouchane AI